Authors: Bastyr, EJ Huang, Y Brunelle, RL Vignati, L Cox, DJ Kotsanos, JG

Citation: Ej. Bastyr et al., Factors associated with nocturnal hypoglycaemia among patients with type 2diabetes new to insulin therapy: experience with insulin lispro, DIABET OB M, 2(1), 2000, pp. 39-46

Authors: Bastyr, EJ Stuart, CA Brodows, RG Schwartz, S Graf, CJ Zagar, A Robertson, KE

Citation: Ej. Bastyr et al., Therapy focused on lowering postprandial glucose, not fasting glucose, maybe superior for lowering HbA(1c), DIABET CARE, 23(9), 2000, pp. 1236-1241

Authors: Jovanovic, L Ilic, S Pettitt, DJ Hugo, K Gutierrez, M Bowsher, RR Bastyr, EJ

Citation: L. Jovanovic et al., Metabolic and immunologic effects of insulin lispro in gestational diabetes, DIABET CARE, 22(9), 1999, pp. 1422-1427

Authors: Bastyr, EJ Johnson, ME Trautmann, ME Anderson, JH Vignati, L

Citation: Ej. Bastyr et al., Insulin lispro in the treatment of patients with type 2 diabetes mellitus after oral agent failure, CLIN THER, 21(10), 1999, pp. 1703-1714